Cookie Preference

This website uses cookies to improve user experience. Please select an option.  Privacy Policy

No cookies except for those necessary for technical reasons are set.


Promoting growth

Long-term partner for start-ups

We have already accompanied over 100 start-up projects. We usually acquire a minority share in the resulting companies.

We continue to support our portfolio companies on their growth trajectory and manage our shares as profitably as possible until exit – or, in the case of floatation or takeovers by listed companies, beyond.

We distribute most of our revenues from the sale of equity and shares to the LifeScience Foundation, which in turn makes them available to its endowing institutes as research grants

Current shareholdings

Peptide active ingredients for the treatment of highly metastatic carcinomas

Therapeutics against various autoimmune disorders

[Translate to English:]

Identification of gene sequences and prediction of protein structure and function

[Translate to English:]

Design, research and development of non-coding RNA-based therapeutics for cardiovascular diseases

[Translate to English:]

Digital health startup developing and operating a dynamic consent platform that enables patients to submit informed consent and connects patients,...

[Translate to English:]

Discovery and development of new chemical entities for treatment of acute and chronic liver diseases

[Translate to English:]

Contract research for medical, technical and other aerosol systems

[Translate to English:]

Novel cell screening technologies for drug development

[Translate to English:]

Qualitative and quantitative measurement of the biological decomposition of toxic waste (contaminated soil)

[Translate to English:]

Novel optoacoustic imaging technology

[Translate to English:]

Development of personalized T cell immunotherapies with a focus on haematological malignancies
Acquisition of Trianta in January 2014

[Translate to English:]

Medtherm GmbH

Advisory service for the application of hyperthermia therapy

[Translate to English:]

Development of small molecules using an innovative endogenous protective mechanism. Primary focus is the development of a first-in-class oral drug for...

[Translate to English:]

Photoionization mass spectrometry for the direct analysis of complex organic gasses and solids

[Translate to English:]

Development of novel therapies to treat highly resistant bacterial infections

[Translate to English:]


Development of T cell receptors (TCRs) for T cell therapy of cancer 

[Translate to English:]

Development of cancer therapies based on tubulysins

[Translate to English:]

Development of pharmaceutical therapies for the treatment of airways-related diseases
Acquisition of Activaero in March 2014

  • Former shareholdings

    • Activaero GmbH

      Inhalation technology and aerosol medicine - Acquisition by Vectura Group in March 2014

    • Bioregeneration GmbH

      Development of products based on Xellulin®

    • BITZ GmbH

      IT solutions for scientific work in biology, biotechnology and health research

    • Clueda AG

      Intelligent big data solutions for semantic extcraction of knowledge - Acquisition by Baader Bank in June 2015

    • Dualis MedTech GmbH

      Fully implantable pulsatile ventricular assist systems with wireless power and data transfer

    • eADMET GmbH

      Web-based solutions for data storage, integration, interpretation and modelling for physico-chemical and ADMET predictions

    • Encepharm GmbH

      Preclinical contract research in the field of mental illness

    • Genomatix GmbH

      Bioinformatics for functional genome analysis

    • NanoRepro GmbH

      Development, manufacturing and marketing of rapid diagnostics (self diagnostics) for domestic use

    • Protectimmun GmbH

      Development of vaccines and drugs for allergies and chronic inflammatory diseases

    • SurgVision B.V.

      Development of optoacoustic imaging technology for use in preclinical and clinical applications - Acquisition by Bracco in October 2017

    • Trianta Immunotherapies GmbH

      T-cell focused therapies for treatment of cancer - Acquisition by Medigene in January 2014

    • TRION Pharma GmbH

      Development of trifuncional antibodies for treatment of cancer - Acquisition by Fresenius Biotech

    • Vakzine Projekt Management GmbH

      Consulting and services for the development of vaccines and biopharmaceuticals from the lab to clinical trials

    • WBC Drug Delivery Technologies

      Liposome-based drug delivery platform for improved application of therapeutics - Acquisition by Klaria Pharma Holding AB in September 2019

    • Zellkraftwerk GmbH

      Development and marketing of high content cytometry devices and tests for diagnosis of infectious diseases based on two platform technologies - Acquisition by Canopy in April 2019